Compare ALTG & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALTG | SIGA |
|---|---|---|
| Founded | 1984 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 223.8M |
| IPO Year | 2019 | 2016 |
| Metric | ALTG | SIGA |
|---|---|---|
| Price | $6.09 | $3.17 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.82 | N/A |
| AVG Volume (30 Days) | 201.3K | ★ 570.9K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 19.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | ★ $1,835,900,000.00 | N/A |
| Revenue This Year | $1.39 | N/A |
| Revenue Next Year | $3.28 | $170.70 |
| P/E Ratio | ★ N/A | $24.23 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.16 | $2.83 |
| 52 Week High | $8.69 | $8.54 |
| Indicator | ALTG | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 46.26 | 45.66 |
| Support Level | $5.75 | $2.87 |
| Resistance Level | $6.45 | $3.32 |
| Average True Range (ATR) | 0.32 | 0.14 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 23.12 | 17.97 |
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling, Construction Equipment, and Master Distribution. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, Pennsylvania, New York, Florida and throughout the New England States, and The Master Distribution segment is engaged in environmental processing equipment distribution with sub dealers throughout the United States and Canada.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.